Veterinary Medicines

PREMELANGE MEDICAMENTEUX Z 30

Authorised
  • Trimethoprim
  • Sulfadiazine
Download as PDF

Product identification

Medicine name:
PREMELANGE MEDICAMENTEUX Z 30
Active substance:
  • Trimethoprim
  • Sulfadiazine
Target species:
  • Cattle
  • Pig
  • Sheep (lamb)
  • Sheep
  • Cattle (calf)
  • Poultry
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Trimethoprim
    12.50
    milligram(s)
    /
    1.00
    gram(s)
  • Sulfadiazine
    62.50
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Premix for medicated feeding stuff
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Milk
        no withdrawal period
    • Pig
      • Meat and offal
        12
        day
    • Sheep (lamb)
      • Meat and offal
        12
        day
    • Sheep
      • Milk
        no withdrawal period
    • Cattle (calf)
      • Meat and offal
        12
        day
    • Poultry
      • Meat and offal
        12
        day
      • Eggs
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01EW10
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Huvepharma S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Huvepharma S.A.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/3585483 8/1992
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 28/04/2025
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 28/04/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."